Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology at the University Hospital of Geneva, discusses the advantages and future of the hybrid PET/MR modality.
[[{"type":"media","view_mode":"media_crop","fid":"8165","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_9348676445430","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"213","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]] Bridging the two complementary modalities of PET and MR has advantages over PET/CT, as a lower dose and more differentiating modality. That's according to Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology and chairman of the Department of Imaging and Medical Informatics at the University Hospital of Geneva. His orgnanization was an early adopter of PET/MR with Philips’ Ingenuity TF, which received FDA clearance in November 2011.
The system includes two devices separated by about 10 feet with a rotating table so the patient can be scanned in the same position in each machine. Data are merged via software. In this podcast, Ratib discusses the advantages of this hybrid modality, what the transition was like for hospital staff, and the future of PET/MR.
[[{"type":"media","view_mode":"media_crop","fid":"11969","attributes":{"alt":"","class":"media-image","id":"media_crop_8968679564714","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"214","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.